Company Profile
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
Latest News
AECOM selected to design New Lisbon Airport
Christopher Nolan’s The Odyssey Continues its Journey in IMAX with Record-Breaking $48 Million Second Weekend
Ipsen’s Bylvay fails in Phase III biliary atresia study
Rothschild & Co Redburn Adjusts PT on Honeywell International to $216 From $214, Keeps Neutral Rating
JPMorgan Adjusts PT on Honeywell International to $262 From $250, Maintains Overweight Rating
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Website | https://www.novonesis.com |
| Audit Risk | 3 |
| Board Risk | 3 |
| Overall Risk | 2 |
| Market Cap | 189.66B |
| Trailing P/E | 42.46 |
| Forward P/E | 23.03 |
| Dividend Rate | 6.5 |
| Dividend Yield | 1.58% |
| Trailing Annual Div. Rate | 0.87 |
| Trailing Annual Div. Yield | 0.21% |
| Trailing EPS | 9.58 |
| Forward EPS | 17.66 |
| Book Value | 176.31 |
| Price-to-Book | 2.31 |
| Enterprise-to-Revenue | 46.03 |
| Enterprise-to-EBITDA | 124.96 |
| Ex-Dividend Date | 03/24/2026 |
| Earnings Date | |
| Earnings Call Date | |
| Earnings Average | 7.47 |
| Earnings Low | 7.47 |
| Earnings High | 7.47 |
| Revenue Average | 8.32B |
| Revenue Low | 8.32B |
| Revenue High | 8.32B |